BRIEF-Lundbeck, Takeda receive CRL from FDA for Trintellix (vortioxetine) sNDA
* Lundbeck and Takeda receive complete response letter from the FDA for Trintellix® (vortioxetine) sNDA
April 18 SCANDIDOS AB:
* SOONCHUNHYANG UNIVERSITY HOSPITAL IN SOUTH KOREA CHOSE DELTA4 PRODUCTS DISCOVER AND PHANTOM+ FOR PATIENT-SPECIFIC QUALITY ASSURANCE OF ADVANCED RADIATION THERAPY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
June 22 A U.S. judge accepted on Thursday major revisions to Arizona's death penalty procedures, such as eliminating paralytic drugs in lethal injections and giving witnesses more access to watch prisoners inside the death chamber, a lawyer for the death row inmates said.